您的位置：首页 > 新闻中心 > 社会 > 正文

半泽直树

钟睒睒无偿捐赠价值超9亿元股票！_我的网站

神雕侠侣

一 | Karan Johar has praised Ranveer Singh for his recent film Dhurandhar. The filmmaker, who directed Singh in Rocky Aur Rani Kii Prem Kahani, took to Instagram's story section to share the poster of the film and expressed his appreciation. KJo wrote, "OUTSTANDING!!! So much respect for ADITYA DHAR RANVEER SINGH SHASHWAT SACHDEVA (my favourite @ranveersingh performance) Congratulations to the entire cast and crew and to @officialjiostudios." Take a look at Karan Johar's post: In Dhurandhar, Ranveer Singh plays Hamza, an Indian spy sent to Pakistan to infiltrate a terror network. Set against the backdrop of the IC-814 hijacking in 1999 and the 2001 Indian Parliament attack, the film follows Ajay Sanyal, the Intelligence Bureau Chief as he assigns Hamza a high-risk mission to dismantle the group operating across the border. Singh's performance as Hamza has been lauded by critics and fans alike. Besides Karan Johar, Hrithik Roshan and Brooklyn Nine Nine star Terry Crews have also praised the film and Singh for his performance. Filmfare's Review of Dhurandhar Filmfare rated the Aditya Dhar directorial 3.5 out of 5. Our reviewer noted, "At the centre of this world stands Ranveer Singh, playing the hard-edged agent who slips into the shadow world of sleeper operatives as a cross-border conspiracy erupts. It’s a performance of restraint, a departure from his flamboyant screen persona. This Ranveer is raw yet internalised, driven yet fraying. The role demands both physical ferocity and emotional weariness, and he delivers both with remarkable control. His silences speak as loudly as his action beats, grounding the film even when its narrative ambitions begin to overtake its focus." Dhurandhar stars an ensemble cast including Singh, Arjun Rampal, R Madhavan, Akshaye Khanna, Sanjay Dutt, Sara Arjun, Rakesh Bedi, Manav Gohil and Danish Pandor among others. Also Read: Karan Johar, Ranveer Singh and Anjali Anand remember Dharmendra as they share BTS moments from Rocky。 K图 603392_0 　　万泰生物（603392）8月25日晚间公告，公司实控人钟睒睒与福建省翔安创新实验室科技发展基金会签署股份捐赠协议，拟无偿捐赠其直接持有的公司3300万股无限售条件流通股，捐赠股份占公司总股本的2.61%。以8月25日最新收盘价28.1元/股计算，对应股份市值为9.27亿元。
　　上市公司表示，本次捐赠旨在支持公共健康与生物医学的前沿研究探索，受赠方持有捐赠股份期间产生的全部收益，以及受赠方后续减持捐赠股份所得资金，专项用于资助公共健康与生物医学前沿研究探索相关的科学研究、人才培养、科技奖励和科技交流等活动。受让方承诺在受让捐赠股份后6个月内不减持捐赠股份。　　最新持股情况显示，本次捐赠前钟睒睒直接持有万泰生物2.24亿股股份，持股比例17.71%，同时通过控股股东养生堂有限公司持股55.82%，合计持股比例73.53%。完成捐赠后，钟睒睒直接持股数量降至1.91亿股，直接持股比例15.10%，合计持股比例变更为70.92%。　　上市公司表示，本次捐赠不会导致公司控股股东、实际控制人发生变化，不会对公司治理结构及持续经营产生重大影响。　　近期万泰生物披露2026年度半年报，今年上半年公司实现营业收入10.48亿元，同比增长24.29%，归母净利润亏损收窄至1.28亿元。报告期内收入增长，主要原因是九价HPV疫苗上市后持续推进终端准入销售放量，疫苗板块营业收入较上年同期增加。（文章来源：证券时报）。